Relationship between synovial fluid levels of glycosaminoglycans, hydroxyproline and general MMP activity and the presence and severity of articular cartilage change on the proximal articular surface of P1

Equine Veterinary Journal

Volumn 37, Issue 1, 2005, Pages 19-25

  Van Den Boom, R ^a   Van Der Harst, M R ^a   Brommer, H ^a   Brama, P A J ^a   Barneveld, A ^a   Van Weeren, P R ^a   DeGroot, J ^b  

^a UTRECHT UNIVERSITY   (Netherlands)

^b TNO   (Netherlands)

Author keywords

Biomarkers; Glycosaminoglycans; Horse; Hydroxyproline; Osteoarthritis; Synovial fluid

Indexed keywords

COLLAGEN; GLYCOSAMINOGLYCAN; HYDROXYPROLINE; MATRIX METALLOPROTEINASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ARTICULAR CARTILAGE; CARTILAGE DEGENERATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; ENZYME ACTIVITY; MEASUREMENT; METACARPOPHALANGEAL JOINT; NONHUMAN; QUANTITATIVE ANALYSIS; SYNOVIAL FLUID;

ANIMALIA; EQUIDAE; EQUUS CABALLUS;

EID: 11844284024     PISSN: 04251644     EISSN: None     Source Type: Journal    
DOI: 10.2746/0425164054406919     Document Type: Article

References (66)

1. Alwan, W.H., Carter, S.D., Bennett, D. and Edwards, G.B. (1991) Glycosaminoglycans in horses with osteoarthritis. Equine vet. J. 23, 44-47.
2. Alwan, W.H., Carter, S.D., Bennett, D., May, S.A. and Edwards, G.B. (1990) Cartilage breakdown in equine osteoarthritis: measurement of keratan sulphate by an ELISA system. Res. vet. Sci. 49, 56-60.
3. Antonas, K.N., Fraser, J.R. and Muirden, K.D. (1973) Distribution of biologically labelled radioactive hyaluronic acid injected into joints. Ann. Rheum. Dis. 32, 103-111.
4. Bank, R.A., Jansen, E.J., Beekman, B. and TeKoppele, J.M. (1996) Amino acid analysis by reverse-phase high-performance liquid chromatography: improved derivatisation and detection conditions with 9-fluorenylmethyl chloroformate. Anal. Biochem. 240, 167-176.
5. Bank, R.A., Krikken, M., Beekman, B., Stoop, R., Maroudas, A., Lafeber, F.P. and TeKoppele, J.M. (1997) A simplified measurement of degraded collagen in tissues: application in healthy, fibrillated and osteoarthritic cartilage. Matrix Biol. 16, 233-243.
6. Belcher, C., Yaqub, R., Fawthrop, F., Bayliss, M. and Doherty, M. (1997) Synovial fluid chondroitin and keratan sulphate epitopes, glycosaminoglycans, and hyaluronan in arthritic and normal knees. Ann. Rheum. Dis. 56, 299-307.
7. Bluteau, G., Conrozier, T., Mathieu, P., Vignon, E., Herbage, D. and Mallein-Gerin, F. (2001) Matrix metalloproteinase-1, -3, -13 and aggrecanase-1 and -2 are differentially expressed in experimental osteoarthritis. Biochim. Biophys. Acta 1526, 147-158.
8. Brama, P.A., TeKoppele, J.M., Beekman, B., van Weeren, P.R. and Barneveld, A. (1998) Matrix metalloproteinase activity in equine synovial fluid: influence of age, osteoarthritis, and osteochondrosis. Ann. Rheum. Dis. 57, 697-699.
9. Brama, P.A., TeKoppele, J.M., Bank, R.A., van Weeren, P.R. and Barneveld, A. (1999) Influence of site and age on biochemical characteristics of the collagen network of equine articular cartilage. Am. J. vet. Res. 60, 341-345.
10. Brama, P.A., TeKoppele, J.M., Bank, R.A., Barneveld, A. and van Weeren, P.R. (2000a) Functional adaptation of equine articular cartilage: the formation of regional biochemical characteristics up to age one year. Equine vet. J. 32, 217-221.
11. Brama, P.A., TeKoppele, J.M., Beekman, B., van El, B., Barneveld, A. and van Weeren, P.R. (2000b) Influence of development and joint pathology on stromelysin enzyme activity in equine synovial fluid. Ann. Rheum. Dis. 59, 155-157.
12. Brommer, H., van Weeren, P.R. and Brama, P.A. (2003a) New approach for quantitative assessment of articular cartilage degeneration in horses with osteoarthritis. Am. J. vet. Res. 64, 83-87.
13. Brommer, H., Brama, P.A.J., Barneveld, A. and van Weeren, P.R. (2003b) Quantification and age-related distribution of articular cartilage degeneration in the equine fetlock joint. Equine vet. J. 35, 697-701.
14. Cantley, C.E., Firth, E.C., Delahunt, J.W., Pfeiffer, D.U. and Thompson, K.G. (1999) Naturally occurring osteoarthritis in the metacarpophalangeal joints of wild horses. Equine vet. J. 31, 73-81.
15. Caterson, B., Flannery, C.R., Hughes, C.E. and Little, C.B. (2000) Mechanisms involved in cartilage proteoglycan catabolism. Matrix Biol. 19, 333-344.
16. Chevalier, X. (1997) Is a biological marker for osteoarthritis within reach? Rev. Rhum. Engl. Edn. 64, 562-577.
17. Chunekamrai, S., Krook, L.P., Lust, G. and Maylin, G.A. (1989) Changes in articular cartilage after intra-articular injections of methylprednisolone acetate in horses Am. J. vet. Res. 50, 1733-1741.
18. Clegg, P.D. and Carter, S.D. (1999) Matrix metalloproteinase-2 and -9 are activated in joint diseases. Equine vet. J. 31, 324-330.
19. Clegg, P.D., Coughlan, A.R., Riggs, C.M. and Carter, S.D. (1997) Matrix metalloproteinases 2 and 9 in equine synovial fluids. Equine vet. J. 29, 343-348.
20. Dahlberg, L., Billinghurst, R.C., Manner, P., Nelson, F., Webb, G., Ionescu, M., Reiner, A., Tanzer, M., Zukor, D., Chen, J., van Wart, H.E. and Poole, A.R. (2000) Selective enhancement of collagenase-mediated cleavage of resident type II collagen in cultured osteoarthritic cartilage and arrest with a synthetic inhibitor that spares collagenase 1 (matrix metalloproteinase 1). Arthritis Rheum. 43, 673-682.
21. DeGroot, J., Bank, R.A., Tchetverikov, I., Verzijl, N. and TeKoppele, J.M. (2002) Molecular markers for osteoarthritis: the road ahead. Curr. Opin. Rheum. 14, 585-589.
22. DeGroot, J., Verzijl, N., Wenting-Van Wijk, M.J., Bank, R.A., Lafeber, F.P., Bijlsma, J.W. and TeKoppele, J.M. (2001) Age-related decrease in susceptibility of human articular cartilage to matrix metalloproteinase-mediated degradation: the role of advanced glycation end products. Arthritis Rheum. 44, 2562-2571.
23. Fuller, C.J., Barr, A.R., Sharif, M. and Dieppe, P.A. (2001) Cross-sectional comparison of synovial fluid biochemical markers in equine osteoarthritis and the correlation of these markers with articular cartilage damage. Osteoarthritis Cartilage 9, 49-55.
24. Heinegard, D., Inerot, S., Wieslander, J. and Lindblad, G. (1985) A method for the quantification of cartilage proteoglycan structures liberated to the synovial fluid during developing degenerative joint disease Scand. J. Clin. Lab. Invest. 45, 421-427.
25. Heinegard, D., Inerot, S., Olsson, S.E. and Saxne, T. (1987) Cartilage proteoglycans in degenerative joint disease. J. Rheumatol. 14, 110-112.
26. Hembry, R.M., Bagga, M.R., Reynolds, J.J. and Kambien, D.L. (1995) Immunolocalisation studies on six matrix metalloproteinases and their inhibitors, TIMP-1 and TIMP-2, in synovia from patients with osteo- and rheumatoid arthritis. Ann. Rheum. Dis. 54, 25-32.
27. Hollander, A.P., Pidoux, I., Reiner, A., Rorabeck, C., Bourne, R. and Poole, A.R. (1995) Damage to type II collagen in aging and osteoarthritis starts at the articular surface, originates around chondrocytes, and extends into the cartilage with progressive degeneration. J. clin. Invest. 96, 2859-2869.
28. Hollander, A.P., Heathfield, T.F., Webber, C., Iwata, Y., Bourne, R., Rorabeck, C. and Poole, A.R. (1994) Increased damage to type II collagen in osteoarthritic articular cartilage detected by a new immunoassay. J. clin. Invest. 93, 1722-1732.
29. Johnson, R.G., Stollery, J., Keeley, F.W. and Herbert, M.A. (1980) Biochemical analysis of rabbit articular cartilage using an amino acid analyzer. Clin. Orthop. 146, 282-288.
30. Jubb, R.W. and Fell, H.B. (1980) The breakdown of collagen by chondrocytes. J. Pathol. 130, 159-167.
31. Kidd, J.A., Fuller, C. and Barr, A.R.S. (2001) Osteoarthritis in the horse. Equine vet. Educ. 13, 160-168.
32. Kraus, V.B., Huebner, J.L., Fink, C., King, J.B., Brown, S., Vail, T.P. and Guilak, F. (2002) Urea as a passive transport marker for arthritis biomarker studies. Arthritis Rheum. 46, 420-427.
33. Little, C.B., Hilbert, B.J., Wickstrom, S. and Hedlund, B.E. (1990) Quantitative microanalysis of equine synovial fluid glycosaminoglycan concentration. Am. J. vet. Res. 51, 1534-1539.
34. Lohmander, L.S., Lark, M.W., Dahlberg, L., Walakovits, L.A. and Roos, H. (1992) Cartilage matrix metabolism in osteoarthritis: markers in synovial fluid, serum, and urine. Clin. Biochem. 25, 167-174.
35. Lohmander, L.S., Roos, H., Dahlberg, L., Hoerrner, L.A. and Lark, M.W. (1994) Temporal patterns of stromelysin-1, tissue inhibitor, and proteoglycan fragments in human knee joint fluid after injury to the cruciate ligament or meniscus. J. Orthop. Res. 12, 21-28.
36. MacDonald, M.H., Tesch, A.M., Benton, H.P. and Willits, N.H. (2002) Characterisation of age- and location-associated variations in the composition of articular cartilage from the equine metacarpophalangeal joint. J. equine vet. Sci. 22, 25-32.
37. Maldonado, R., Garces, H., Auba, J. and Horvath, A. (1983) Synovial aldehyde groups in equine joint disease. Equine vet. J. 15, 168-169.
38. Manicourt, D.H., Fujimoto, N., Obata, K. and Thonar, E.J. (1994) Serum levels of collagenase, stromelysin-1, and TIMP-1. Age- and sex- related differences in normal subjects and relationship to the extent of joint involvement and serum levels of antigenic keratan sulfate in patients with osteoarthritis. Arthritis Rheum. 37, 1774-1783.
39. Maroudas, A., Evans, H. and Almeida, L. (1973) Cartilage of the hip joint. Topographical variation of glycosaminoglycan content in normal and fibrillated tissue. Ann. Rheum. Dis. 32, 1-9.
40. McIlwraith, C.W. (1996) General pathobiology of the joint and response to injury. In: Joint Disease in the Horse, Eds: C.W McIlwraith and G.W Trotter, W.B. Saunders Co., Philadelphia. pp 40-70.
41. Mitchell, P.G., Magna, H.A., Reeves, L.M., Lopresti-Morrow, L.L., Yocum, S.A., Rosner, P.J., Geoghegan, K.F. and Hambor, J.E. (1996) Cloning, expression, and type II collagenolytic activity of matrix metalloproteinase-13 from human osteoarthritic cartilage. J. clin. Invest. 97, 761-768.
42. Miyaguchi, M., Kobayashi, A., Kadoya, Y., Ohashi, H., Yamano, Y. and Takaoka, K. (2003) Biochemical change in joint fluid after isometric quadriceps exercise for patients with osteoarthritis of the knee. Osteoarthritis Cartilage. 11, 252-259.
43. Murphy, G., Hembry, R.M., Hughes, C.E., Fosang, A.J. and Hardingham, T.E. (1990) Role and regulation of metalloproteinases in connective tissue turnover. Biochem. Soc. Trans. 18, 812-815.
44. Myers, S.L., O'Connor, B.L. and Brandt, K.D. (1996) Accelerated clearance of albumin from the osteoarthritic knee: implications for interpretation of concentrations of 'cartilage markers' in synovial fluid. J. Rheumatol. 23, 1744-1748.
45. Okumura, M., Kim, G.H., Tagami, M., Haramaki, S. and Fujinaga, T. (2002) Serum keratan sulphate as a cartilage metabolic marker in horses: the effect of exercise. J. vet. med. A Physiol. Path. clin. Med. 49, 195-197.
46. Olivier, A., Nurton, J.P. and Guthrie, A.J. (1997) An epizoological study of wastage in thoroughbred racehorses in Gauteng, South Africa. J. S. Afr. vet. Ass. 68, 125-129.
47. Otterness, I.G., Eskra, J.D., Bliven, M.L., Shay, A.K., Pelletier, J.P. and Milici, A.J. (1998) Exercise protects against articular cartilage degeneration in the hamster. Arthritis Rheum. 41, 2068-2076.
48. Owens, J.G., Kamerling, S.G., Stanton, S.R., Keowen, M.L. and Prescott-Mathews, J.S. (1996) Effects of pretreatment with ketoprofen and phenylbutazone on experimentally induced synovitis in horses. Am. J. vet. Res. 57, 866-874.
49. Palmer, J.L., Bertone, A.L. and McClain, H. (1995) Assessment of glycosaminoglycan concentration in equine synovial fluid as a marker of joint disease. Can. J. vet. Res. 59, 205-212.
50. Pool, R.R. (1996) Pathologic manifestations of joint disease in the athletic horse. In: Joint Disease in the Horse, Eds: C.W McIlwraith and G.W. Trotter, W.B. Saunders Co., Philadelphia. pp 87-104.
51. Ratcliffe, A., Doherty, M., Maini, R.N. and Hardingham, T.E. (1988) Increased concentrations of proteoglycan components in the synovial fluids of patients with acute but not chronic joint disease. Ann. Rheum. Dis. 47, 826-832.
52. Reboul, P., Pelletier, J.P., Tardif, G., Cloutier, J.M. and Martel-Pelletier, J. (1996) The new collagenase, collagenase-3, is expressed and synthesised by human chondrocytes but not by synoviocytes. A role in osteoarthritis. J. clin. Invest. 97, 2011-2019.
53. Rossdale, P.D., Hopes, R., Wingfield Digby, N.J. and Offord, K. (1985) Epidemiological study of wastage among racehorses 1982 and 1983. Vet. Rec. 116, 66-69.
54. Saxne, T., Heinegard, D. and Wollheim, F.A. (1986) Therapeutic effects on cartilage metabolism in arthritis as measured by release of proteoglycan structures into the synovial fluid. Ann. Rheum. Dis. 45, 491-497.
55. Saxne, T., Heinegard, D., Wollheim, F.A. and Pettersson, H. (1985) Difference in cartilage proteoglycan level in synovial fluid in early rheumatoid arthritis and reactive arthritis. Lancet 326, 127-128.
56. Shlopov, B.V., Lie, W.R., Mainardi, C.L., Cole, A.A., Chubinskaya, S. and Hasty, K.A. (1997) Osteoarthritic lesions: involvement of three different collagenases. Arthritis Rheum. 40, 2065-2074.
57. Sweet, M.B., Thonar, E.J., Immelman, A.R. and Solomon, L. (1977) Biochemical changes in progressive osteoarthrosis. Ann. Rheum. Dis. 36, 387-398.
58. Todhunter, R.J. (1992) Synovial joint anatomy, biology and pathobiology. In: Equine Surgery, Ed: J.A. Auer, W.B. Saunders Co., Philadelphia. pp 844-866.
59. Todhunter, R.J. (1996) Anatomy and physiology of synovial joints. In: Joint Disease in the Horse, Eds: C.W. McIlwraith and G.W. Trotter, W.B. Saunders Co., Philadelphia. pp 1-28.
60. Todhunter, R.J. and Lust, G. (1990) Pathophysiology of synovitis: Clinical signs and examination in horses. Comp. cont. Educ. pract. Vet. 12, 980-992.
61. Trotter, G.W. and McIlwraith, C.W. (Eds) (1996) Clinical features and diagnosis of equine joint disease. In: Joint Disease in the Horse, W.B. Saunders Co., Philadelphia. pp 120-145.
62. Vachon, A.M., Keeley, F.W., McIlwraith, C.W. and Chapman, P. (1990) Biochemical analysis of normal articular cartilage in horses. Am. J. vet. Res. 51, 1905-1911.
63. van den Hoogen, B.M., van de Lest, C.H., van Weeren, P.R., Lafeber, F.P., Lopes-Cardozo, M., van Golde, L.M. and Barneveld, A. (1998) Loading-induced changes in synovial fluid affect cartilage metabolism. Br. J. Rheumatol. 37, 671-676.
64. Van Pelt, R.W. (1963) Clinical and synovial fluid response to intra-articular synovial injection of 6α-methylprednisolone acetate into horses and cattle. J. Am. vet. med. Ass. 143, 738-748.
65. Westacott, C.I. and Sharif, M. (1996) Cytokines in osteoarthritis: mediators or markers of joint destruction? Semin. Arthritis Rheum. 25, 254-272.
66. Worrall, J.G., Wilkinson, L.S., Bayliss, M.T. and Edwards, J.C. (1994) Zonal distribution of chondroitin-4-sulphate/dermatan sulphate and chondroitin-6-sulphate in normal and diseased human synovium. Ann. Rheum. Dis. 53, 35-38.